Nuvectis Pharma
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -6,260 | -8,210 | -7,462 | -6,334 |
EBIT | -6,595 | |||
Net Income | -6,050 | -7,314 | -7,462 | -6,334 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,511 | -3,974 | -4,494 | -3,367 |
Cash | 25,130 | 31,634 | 35,442 | 26,793 |
Basic Shares | 23,414 | 21,812 | 22,719 | 21,366 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $149 |
Gross Profit | -22,897 | -19,085 | ||
EBITDA | -27,574 | -19,000 | -22,897 | -18,936 |
EBIT | -19,847 | -21,897 | -19,234 | |
Net Income | -26,442 | -19,000 | -22,260 | -18,787 |
Net Change In Cash | 0 | 0 | 0 | 149 |
Cost of Revenue | 14,251 | |||
Free Cash Flow | -16,009 | -12,247 | -15,954 | -13,559 |
Cash | 31,634 | 18,533 | 19,126 | 19,993 |
Basic Shares | 21,812 | 17,113 | 15,556 | 12,657 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.26 |
2025-12-31 | -$0.31 |
2025-09-30 | -$0.44 |
2025-06-30 | -$0.30 |